一种选择性S-化蛋白调节胰岛素信号的酶
Hua-Lin Zhou1, Zachary W Grimmett2, Nicholas M Venetos3
1Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Institute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Cell
|December 6, 2023
概括
一种新发现的酶SCAN使用S-nitroso-CoA (SNO-CoA) 来对S-nitrosylate蛋白质产生影响,从而影响胰岛素信号传递. 这种酶
科学领域:
- 生物化学
- 分子生物学
- 酵素学
背景情况:
- 乙-辅酶A (乙-CoA) 分子是蛋白质乙化过程中必不可少的辅因子.
- 蛋白质S-化是一种具有不同生物作用的关键转化后修饰.
研究的目的:
- 用S-nitroso-CoA (SNO-CoA) 作为辅助因子识别和描述一种新型酶.
- 阐明该酶在调节蛋白质S-化和胰岛素信号传递中的作用.
主要方法:
- 酶净化和SNO-CoA辅助化酶 (SCAN) 的表征
- 在体外测定SNO从SNO-CoA转移到蛋白质基质.
- 在小鼠体内的研究和人类组织样本的分析.
主要成果:
- SCAN可以选择性地将SNO组从SNO- CoA转移到蛋白质中,包括胰岛素受体 (INSR) 和胰岛素受体基质1 (IRS1).
- 胰岛素刺激的SCAN活性会降低胰岛素信号;肥胖症中SCAN活性增加会导致超化和胰岛素抵抗.
- 缺少SCAN的小鼠显示出对糖尿病的保护;人类的SCAN表达与体重指数和INSR S- 化相关.
结论:
- SCAN 是一种通过SNO-CoA催化S-化酶的新类酶.
- 对于像INSR这样的受体氨酸激酶,SCAN调节了一种新的调节机制.
- 这一发现修订了对氧化 (NO) 在生理学和疾病,特别是代谢障碍中的作用的理解.
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Protein Modifications in the RER
5.2K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.2K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K


